• contact
  • |
  • site map
  • |
  • careers
 
  • Home
  • About Us
    • Overview
    • Executive Team
    • Board of Directors
    • Collaborations
    • Mission
    • Corporate History
    • Advisors
  • Technology
    • Overview
    • Innovation @ Chikujee
    • Focused Diversification
    • Drug Development
    • Advantages
    • Personalized Healthcare
    • Clinical Trials
  • Products
    • Overview
    • Autism
    • Targeted Therapeutics
    • Biomarker Monitoring
    • Personalized Products
  • Investors
    • Overview
    • Investment Highlights
    • IP Strategy
    • Business Strategy
    • Investor Contacts
  • News & Events
    • News
    • Events
    • Corporate Fact Sheet
    • Corporate Library
    • Media Contacts
    • Join Mailing List
  • Careers
    • Overview
    • Culture
    • Diversity
    • Job Opportunities

Home › Overview › Overview
  • Overview
  • Investment Highlights
  • IP Strategy
  • Business Strategy
  • Investor Contacts
  • Sustainable Growth


 

Investment Overview

 

 

Chikujee Therapeutics is an integrated biopharmaceutical company that applies its innovative drug development & commercialization Platform to generate a pipeline of personalized medicine products to detect, treat and monitor cancer. Chikujee’s Aayush platform includes a complementary portfolio of personalized diagnostics, targeted therapeutics and reporters of efficacy to create novel disease-specific personalized medicine products. The approach takes the product development a step further that the current combination products (different but packaged together diagnostics and therapeutics), by integrating them in one integrated product with diagnostic, therapeutic and monitoring capabilities.

 

Chikujee Therapeutics is a privately owned company. To inquire about investment opportunities, please contact

 investor.relations@Chikujee.com.

 

© 2012 Chikujee Therapeutics | Privacy Policy | Terms of Use | Join Mailing List